Skip to main
GLSHQ
GLSHQ logo

Gelesis Holdings Inc (GLSHQ)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GLSHQ Stock

About Gelesis Holdings Inc (GLSHQ)

Gelesis Holdings, Inc. operates as a biotechnology company. The firm engages in developing a novel category of therapies for weight management and gut related chronic diseases. The company was founded on February 15, 2006 and is headquartered in Boston, MA.
Market cap$100
Today's volume
Revenue (TTM)
Avg. daily volume263.53
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)62.13x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for GLSHQ stock is $100

The 52-week high for GLSHQ stock is $0.00. The current GLSHQ stock price $undefined is 100.00% below its 52-week high

No, the GLSHQ stock does not pay dividends to its shareholders

How to buy GLSHQ stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GLSHQ stock

    Navigate to the Explore page. Then, type GLSHQ into the search bar. When you see GLSHQ stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GLSHQ stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy GLSHQ Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.